162 related articles for article (PubMed ID: 1391437)
1. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characteristics of hemoglobin intramolecularly cross-linked and polymerized.
Berbers GA; Bleeker WK; Stekkinger P; Agterberg J; Rigter G; Bakker JC
J Lab Clin Med; 1991 Feb; 117(2):157-65. PubMed ID: 1993858
[TBL] [Abstract][Full Text] [Related]
3. Purification and physical characteristics of a hemoglobin solution modified by coupling to 2-nor-2-formylpyridoxal 5'-phosphate (NFPLP).
van der Plas J; de Vries-Van Rossen A; Koorevaar JJ; Buursma A; Zijlstra WG; Bakker JC
Transfusion; 1988; 28(6):525-30. PubMed ID: 2461607
[TBL] [Abstract][Full Text] [Related]
4. Prolonged vascular retention of a hemoglobin solution modified by cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate.
Bleeker WK; van der Plas J; Agterberg J; Rigter G; Bakker JC
J Lab Clin Med; 1986 Nov; 108(5):448-55. PubMed ID: 3772225
[TBL] [Abstract][Full Text] [Related]
5. The role of the kidneys in the excretion of chemically modified hemoglobins.
Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Winslow RM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):737-45. PubMed ID: 1391505
[TBL] [Abstract][Full Text] [Related]
6. Preparation and physical characteristics of a hemoglobin solution modified by coupling to 2-nor-2-formylpyridoxal 5'-phosphate.
van der Plas J; de Vries-van Rossen A; Damm JB; Bakker JC
Transfusion; 1987; 27(5):425-30. PubMed ID: 3629674
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-transport and solution properties of polylipid/Hb vesicles (ARC).
Takeoka S; Hasegawa E; Nishide H; Tsuchida E; Sekiguchi S
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):399-404. PubMed ID: 1391455
[TBL] [Abstract][Full Text] [Related]
8. A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization.
Prouchayret F; Fasan G; Grandgeorge M; Vigneron C; Menu P; Dellacherie E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):319-22. PubMed ID: 1382641
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro characteristics of polymerized pyridoxylated hemoglobin.
Sehgal LR; Rosen AL; Gould SA; Sehgal HL; Moss GS
Transfusion; 1983; 23(2):158-62. PubMed ID: 6404022
[TBL] [Abstract][Full Text] [Related]
10. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate.
Bleeker WK; van der Plas J; Feitsma RI; Agterberg J; Rigter G; de Vries-van Rossen A; Pauwels EK; Bakker JC
J Lab Clin Med; 1989 Feb; 113(2):151-61. PubMed ID: 2915180
[TBL] [Abstract][Full Text] [Related]
11. A natural compound (reuterin) produced by Lactobacillus reuteri for hemoglobin polymerization as a blood substitute.
Chen YC; Chang WH; Chang Y; Huang CM; Sung HW
Biotechnol Bioeng; 2004 Jul; 87(1):34-42. PubMed ID: 15211486
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin polymerized with a naturally occurring crosslinking agent as a blood substitute: in vitro and in vivo studies.
Chang WH; Chang Y; Chen YC; Sung HW
Artif Cells Blood Substit Immobil Biotechnol; 2004 May; 32(2):243-62. PubMed ID: 15274431
[TBL] [Abstract][Full Text] [Related]
13. [Study of polymerizing hemoglobin on cation exchange chromatography].
Wang X; Huang L; Yang C; Wang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1146-9. PubMed ID: 19024464
[TBL] [Abstract][Full Text] [Related]
14. Influence of the polymerization step alone on oxygen affinity and cooperativity during production of hyperpolymers from native hemoglobins with crosslinkers.
Barnikol WK
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):725-31. PubMed ID: 7994394
[TBL] [Abstract][Full Text] [Related]
15. Fine tuning of polymerized pyridoxylated hemoglobin as a red blood cell substitute.
Hsia CJ
Prog Clin Biol Res; 1989; 319():339-49. PubMed ID: 2622918
[TBL] [Abstract][Full Text] [Related]
16. Effect of polymerization on clearance and degradation of free hemoglobin.
Bleeker WK; Berbers GA; den Boer PJ; Agterberg J; Rigter G; Bakker JC
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):747-50. PubMed ID: 1391506
[TBL] [Abstract][Full Text] [Related]
17. Molecular weight determinations of o-raffinose-polymerized human hemoglobin.
Moore GL; Fishman RM; Ledford ME; Zegna A; Hsia JC; Song DL; Wong LT; Er SS
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):293-6. PubMed ID: 1391445
[No Abstract] [Full Text] [Related]
18. Synthesis, physico-chemical and biological properties of crosslinked modified hemoglobin.
Kuznetsova NP; Gudkin LR; Mishaeva RN; Stragovich LM; Bistrova IM; Selivanov EA
Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):213-22. PubMed ID: 9564439
[TBL] [Abstract][Full Text] [Related]
19. Effect of coupling of 2-nor-2-formylpyridoxal 5'-phosphate to stroma-free hemoglobin on oxygen affinity and tissue oxygenation. Studies in the isolated perfused rat liver under conditions of normoxia and stagnant hypoxia.
Van der Plas J; de Vries-van Rossen A; Bleeker WK; Bakker JC
J Lab Clin Med; 1986 Sep; 108(3):253-60. PubMed ID: 3746098
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated hemoglobin processing methods.
Zheng S; Zheng Y; Beissinger RL; Fresco R
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):355-64. PubMed ID: 1391451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
